HOWL · Werewolf Therapeutics, Inc. · Share Buybacks
$0.90
-0.03 (-3.22%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jul 31, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe there is substantial doubt about our ability to continue as a going concern for at least twelve months from the date that these condensed consolidated financial statements are issued in this Quarterly Report. We are currently evaluating strategies to raise additional capital, however, there can be no assurances that we will be successful in mitigating the conditions which raise substantial doubt about our ability to continue as a going concern in the near term, if at all.”View the 10-Q filed Jul 31, 2026
Market Cap
$46.65M
Shares
48.60M
Volume · Oct 5
239.08K
Avg daily vol (3M)
6.73M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-05-10 | 2024-02 | $12,500,000 | — | — | 10-Q , filed 2026-07-31 |